BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing critical-care products for the hospital setting, today announced that Howard Weisman, CEO & President, will present at the UBS Global Life Sciences Conference on Tuesday, September 22 at 10:00 a.m. ET. The conference will be held from September 21 - 23, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central in New York City.
